e.l.f. Cosmetics
ELF
$50.72
-4.27%
e.l.f. Beauty, Inc. is a multi-brand beauty company operating in the consumer defensive sector, specifically within the household & personal products industry. It is a disruptive player in the cosmetics and skincare market, distinguished by its mission to offer inclusive, accessible, clean, vegan, and cruelty-free products at an affordable price point. The current investor narrative is intensely focused on the stock's dramatic price decline amidst conflicting signals of strong revenue growth and significant profit margin compression, as highlighted by recent news debating whether the steep drop presents a buying opportunity for a high-growth company now trading at a discount, or if margin pressures and a high absolute valuation make it a risky proposition.…
ELF
e.l.f. Cosmetics
$50.72
Related headlines
ELF 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on e.l.f. Cosmetics's 12-month outlook, with a consensus price target around $65.94 and implied upside of +30.0% versus the current price.
Average Target
$65.94
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$41 - $66
Analyst target range
Institutional analyst coverage shows a generally bullish stance, with recent actions from firms like TD Cowen, JP Morgan, and Citigroup maintaining 'Buy' or 'Overweight' ratings, while UBS and Piper Sandler hold 'Neutral' positions. However, the provided dataset indicates coverage from only one analyst for quantitative estimates, with an average revenue estimate of approximately $2.31 billion. The limited quantitative analyst data (num_analysts: 1) suggests insufficient coverage to derive a meaningful consensus price target or implied upside/downside. This limited coverage is typical for a mid-cap growth stock like ELF and can lead to higher volatility and less efficient price discovery, as the investment thesis is less vetted by the broader analyst community. The recent news headlines reflect this high-conviction but niche debate, framing the stock's steep decline as a potential buying opportunity for explosive revenue growth at a discounted valuation, versus a warning on profit margin declines and high absolute valuation.
Bulls vs Bears: ELF Investment Factors
The investment debate for ELF is a classic clash between explosive growth and deteriorating profitability. The bull case, supported by 37.8% revenue growth and a reasonable forward P/E of 15.7x, argues that the market has over-penalized a high-quality growth story now trading near its lows. The bear case, anchored by a 42% year-over-year net margin decline and extreme stock volatility (beta 2.389), contends that profitability challenges are structural and justify the steep sell-off. Currently, the bear side has stronger short-term evidence, as the severe technical breakdown and margin compression are concrete, present-tense facts, while the bull case relies on future earnings growth to materialize. The single most important tension is whether management can stabilize and expand net margins back towards historical levels while maintaining its torrid revenue growth—the resolution of this margin trajectory will determine if the stock is a deep-value turnaround or a value trap.
Bullish
- Explosive Revenue Growth: Revenue grew 37.8% YoY in Q3 FY2026 to $489.5M, demonstrating sustained top-line momentum. This growth rate is exceptional for a consumer defensive company and validates strong market demand for ELF's product portfolio.
- Attractive Forward Valuation: The forward P/E of 15.7x is less than half the trailing P/E of 31.5x, indicating the market expects significant earnings growth. This forward multiple suggests the stock is reasonably priced if the company can meet its earnings projections.
- Strong Balance Sheet & Cash Flow: The company maintains a robust current ratio of 3.05 and a manageable debt-to-equity of 0.41. TTM free cash flow of $214.5M provides ample internal capital to fund growth initiatives without excessive leverage.
- Deeply Oversold Technicals: Trading at only 37% of its 52-week range and down 27.8% over the past year, the stock is near its 52-week low of $52.78. This extreme pessimism, with a -53.01% relative strength vs. the S&P 500, may have priced in significant bad news.
Bearish
- Severe Profit Margin Compression: Net margin collapsed to 8.5% in Q3 FY2026 from 14.7% a year prior, a 42% decline. This sharp deterioration in profitability, despite strong revenue growth, raises serious questions about operating leverage and cost management.
- Extreme Price Volatility & Downtrend: The stock has a beta of 2.389, making it over 138% more volatile than the market, and has suffered a max drawdown of -63.36%. It is in a severe downtrend, down 30.8% over the past three months, indicating persistent and aggressive selling pressure.
- Elevated Trailing Valuation: A trailing P/E of 31.5x is high for a company experiencing significant margin pressure. This valuation leaves little room for error and requires flawless execution on future earnings growth to justify.
- Limited Analyst Coverage: Quantitative analyst coverage is limited (num_analysts: 1), leading to less efficient price discovery and higher volatility. The lack of a broad consensus target increases uncertainty for investors.
ELF Technical Analysis
The stock is in a severe and sustained downtrend, with the 1-year price change of -27.82% significantly underperforming the S&P 500's +25.19% gain, resulting in a relative strength of -53.01%. As of the latest close at $56.43, the price is trading at only 37% of its 52-week range ($52.78 to $150.99), indicating it is deeply oversold and near its 52-week low, which suggests either a major value opportunity or a fundamental deterioration that has yet to find a bottom. The short-term momentum is decisively negative and accelerating the longer-term decline, with the stock down 19.22% over the past month and 30.76% over the past three months, far worse than the market's positive returns over the same periods. This severe underperformance, coupled with a high beta of 2.389 indicating the stock is over 138% more volatile than the market, underscores extreme selling pressure and high risk. Key technical levels are clearly defined, with the 52-week low of $52.78 acting as critical support; a decisive breakdown below this level could trigger another leg down. Conversely, any recovery would face significant resistance near the 52-week high of $150.99. The stock's extreme volatility, evidenced by a max drawdown of -63.36%, necessitates careful position sizing and risk management for any investors considering a contrarian entry.
Beta
2.39
2.39x market volatility
Max Drawdown
-65.4%
Largest decline past year
52-Week Range
$50-$151
Price range past year
Annual Return
-37.8%
Cumulative gain past year
| Period | ELF Return | S&P 500 |
|---|---|---|
| 1m | -25.9% | +4.6% |
| 3m | -44.3% | +8.3% |
| 6m | -27.6% | +12.5% |
| 1y | -37.8% | +25.0% |
| ytd | -34.8% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ELF Fundamental Analysis
Revenue growth remains exceptionally strong, with the most recent quarterly (Q3 FY2026) revenue of $489.5 million representing a 37.8% year-over-year increase, continuing a multi-quarter trend of explosive top-line expansion. However, profitability metrics reveal significant pressure; while the company is profitable with net income of $39.4 million in the latest quarter, the net margin of 8.5% represents a sharp decline from the 14.7% net margin reported in the same quarter a year prior (Q1 FY2025), indicating margin compression despite revenue growth. The gross margin remains robust at 71.0% for the quarter, but operating leverage appears challenged as costs rise. The balance sheet and cash flow position is mixed; the company maintains a strong current ratio of 3.05 and a manageable debt-to-equity ratio of 0.41, suggesting solid liquidity and moderate leverage. Trailing twelve-month free cash flow is a healthy $214.5 million, providing internal funding for growth, and Return on Equity (ROE) of 14.7% indicates efficient use of shareholder capital. However, recent quarterly cash flow statements show significant volatility, including a large acquisition-related outflow in Q2 FY2026, which investors should monitor for consistency.
Quarterly Revenue
$489505000.0B
2025-12
Revenue YoY Growth
+0.37%
YoY Comparison
Gross Margin
+0.70%
Latest Quarter
Free Cash Flow
$214530000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ELF Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio stands at 31.5x, while the forward P/E is notably lower at 15.7x, indicating the market expects significant earnings growth to justify the current price. Compared to sector averages, e.l.f. Beauty's valuation presents a complex picture; its trailing P/E of 31.5x is elevated, but the forward P/E of 15.7x suggests a more reasonable multiple if earnings projections are met, though direct industry average data is not provided for a precise premium/discount calculation. Historically, the stock's own valuation has compressed dramatically; the current trailing P/E of 31.5x is near the lower end of its recent historical range, which has seen ratios as high as 645x during periods of minimal earnings (Q2 FY2026) and as low as 28.6x (Q3 FY2026). Trading near the bottom of its own historical band suggests the market has already priced in significant pessimism, potentially creating a value opportunity if the company's growth and margin trajectory stabilizes.
PE
64.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -13970x~645x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
31.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on severe and rapid profit margin compression. The net margin fell from 14.7% to 8.5% year-over-year in Q3 FY2026, a decline that, if sustained, threatens to erode the earnings growth implied by the forward P/E of 15.7x. Furthermore, quarterly earnings have shown high volatility, with net income swinging from $47.6M to $3.0M between recent quarters, indicating potential operational instability or lumpy investment spending. While the balance sheet is solid, the company's valuation remains highly dependent on delivering on aggressive future earnings projections, creating significant execution risk.
Market & Competitive Risks are heightened by the stock's extreme valuation multiple compression and high sensitivity to market movements. Trading at a trailing P/E of 31.5x, even after its steep decline, the stock remains vulnerable to further de-rating if growth expectations waver, especially in a higher interest rate environment that pressures growth stock valuations. Its beta of 2.389 means it is likely to fall more than twice as hard as the market in a broad sell-off. Competitive risks are inherent in the fast-moving beauty sector, where brand loyalty can be fickle and maintaining a 37.8% growth rate against larger, well-funded rivals is a formidable challenge.
Worst-Case Scenario involves a continuation of the current margin erosion coupled with a growth slowdown, triggering a full valuation collapse. In this adverse scenario, the forward earnings multiple could compress further, and the stock could re-test and break its critical 52-week low support of $52.78. Given the stock's history of a -63.36% max drawdown, a realistic downside from the current price of $56.43 could be in the range of -20% to -30%, potentially driving the stock into the low-$40s. This would likely be catalyzed by a significant earnings miss, guidance reduction, or loss of market share to a competitor, confirming investor fears about the sustainability of its business model.